Trial Profile
A prospective, multicenter, double-blinded, randomized study to evaluated bleeding patterns in women using one of three different doses of DR-1031 oral contraceptive compared to Seasonale oral contraceptive regimen
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary)
- Indications Pregnancy
- Focus Pharmacodynamics
- Sponsors Duramed Pharmaceuticals Inc
- 07 Oct 2008 Actual end date (March 2008) added as reported by ClinicalTrials.gov
- 07 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 07 Jun 2007 Status changed from recruiting to in progress.